At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Eli Lilly leads incretins via Zepbound/Mounjaro, retatrutide at 28.7% loss, $50B R&D and US buildout, 2025 guidance, ...

It’s 2025, and the world is evolving at a rate that no one thought was possible a decade ago! With globalization in full swing, the world has changed first. Meanwhile, the rapid evolution of social ...

Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease December 9, 2025 4:15 ...

Yet, share markets typically move higher, as has been the case in 2025. This year, the ASX 200 is up 9%, the S&P 500 has risen 18% while the Nasdaq Composite has climbed 23% (all quoted are total ...

The vigorous enforcement of marijuana laws has resulted in four million arrests since the early 1980s. Owing to mandatory-minimum sentences, many of those co ...

Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Various factors determine the best time to take your blood sugar medications, including how the medication works and its side effects.

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...